Which phase of a clinical trial focuses on testing a drug's efficacy and safety in patients?

Which phase of a clinical trial focuses on testing a drug's efficacy and safety in patients?

• A. Phase 1 trial
• B. Phase 2 trial
• C. Phase 3 trial
• D. Phase 4 trial

Answer: (B)

The phase of a clinical trial that focuses on testing a drug's efficacy and safety in patients is Phase 2. During this stage, the drug is administered to a larger group of patients who have the condition that the drug aims to treat, allowing researchers to evaluate its therapeutic effects while also monitoring for any side effects. Phase 2 trials typically involve dose-ranging studies that help determine the optimal dose for further testing. They are crucial because they provide early evidence of whether the drug is effective, which informs the decision to proceed to larger Phase 3 trials. In contrast, Phase 1 trials primarily concentrate on assessing the safety and tolerability of a drug in a small group of healthy volunteers or patients, while Phase 3 trials are designed to confirm efficacy, monitor side effects, and compare the drug to standard or placebo treatments in a broader population. Phase 4 trials occur after a drug has been approved for marketing and involve ongoing monitoring for long-term effects and further assessment of efficacy in the general population.

The phase of a clinical trial that focuses on testing a drug's efficacy and safety in patients is Phase 2. During this stage, the drug is administered to a larger group of patients who have the condition that the drug aims to treat, allowing researchers to evaluate its therapeutic effects while also monitoring for any side effects.

Phase 2 trials typically involve dose-ranging studies that help determine the optimal dose for further testing. They are crucial because they provide early evidence of whether the drug is effective, which informs the decision to proceed to larger Phase 3 trials. In contrast, Phase 1 trials primarily concentrate on assessing the safety and tolerability of a drug in a small group of healthy volunteers or patients, while Phase 3 trials are designed to confirm efficacy, monitor side effects, and compare the drug to standard or placebo treatments in a broader population. Phase 4 trials occur after a drug has been approved for marketing and involve ongoing monitoring for long-term effects and further assessment of efficacy in the general population.